Diurnal has entered into a number of licensing and distribution deals in geographies outside of its core European markets.
 | Consilient Health | Marketing and distribution agreements for Alkindi and Efmody | Sweden, Norway, Denmark, Finland, Iceland (Efmody only) Netherlands, Belgium, Luxembourg (Alkindi and Efmody) |
 | Eton Pharmaceuticals | Exclusive licence for Alkindi | United States, Canada |
 | EffRx Pharmaceuticals SA | Marketing and distribution agreements for Alkindi and Efmody | Switzerland, Lichtenstein |
 | Er-Kim | Marketing and distribution agreements for Alkindi and Efmody | Turkey, Bulgaria, Romania, Greece, Cyprus and Malta |
 | ExCEEd Orphan | Marketing and distribution agreements for Alkindi and Efmody | CEE countries including; Albania, Bosnia and Herzegovina, Croatia, Czechia, Hungary, Kosovo, Montenegro, North Macedonia, Poland, Serbia, Slovakia, and Slovenia. |
 | Medomie Pharma | Marketing and distribution agreements for Alkindi and Efmody | Israel, Palestinian Authority |
 | RareStone | Exclusive licence for Alkindi and Efmody | China, Hong Kong,Taiwan and Macau |
 | FrostPharma | Marketing and distribution agreements for Alkindi | Sweden, Norway, Denmark, Finland, Iceland |